Candidate intelligence for executive search.
Departure signals, warm paths, and the context that makes the first call land.
Ask Orqa about your book...
+8
David Kowalski
CEO, Vantage Therapeutics
David Kowalski
CEO, Vantage Therapeutics · San Francisco, CA
KKR acquired Vantage Therapeutics in April. New PE ownership typically triggers leadership turnover within 12-18 months.
Completed the $800M Meridian partnership in Q1. Major milestone delivered. Pattern suggests openness to next chapter.
Co-trustee, Memorial Sloan Kettering. Meets quarterly.
Stanford GSB, same section, 2002. Still in touch.
Former direct report at Genentech, 2016-2019.
From signal to placement.
Candidate intelligence that goes beyond LinkedIn Recruiter and your proprietary database. Departure signals, warm paths, and the context that makes the first call land.
Detect
Spot departure signals before they surface. PE acquisitions, board turnover, project completions, organizational shifts that signal a candidate is ready to move.
Qualify
Understand the full picture. Career trajectory, board seats, institutional ties, family context. Know who fits the mandate before the first call.
Reach
Find the warm path. Your partners' board connections, alumni overlap, former colleagues. Make the introduction feel natural, not cold.
How Orqa handles data.
Proprietary evidence base
Orqa draws from public data and authorized data partnerships: regulatory filings, property records, institutional affiliations, and news coverage.
Not for regulated decisions
Orqa is not a consumer reporting agency. We are not used for consumer credit, employment screening, insurance underwriting, or tenant-screening decisions.
Data isolation & security
Your data stays yours. Fully isolated infrastructure, no cross-client access, no data resale.
Try it on your candidate list.
Share your current mandates. We will show you candidates with departure signals and warm paths to reach them.